Analgesic effect of continuous transversus abdominis plane block for renal transplant recipients.

Analgesic effect of continuous transversus abdominis plane block for renal transplant recipients. - Analgesic effect of continuous transversus abdominis plane block for renal transplant recipients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013319

Enrollment

Registered

2014-03-03

Start date

2015-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are scheduled for renal transplant from living donor

Interventions

Patients will receive a standardized general anesthetic with multimodal analgesia including IV-PCA fentanyl and ultrasound-guided transversus abdominis plane block. They will receive analgesia through

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled for renal transplant from living donor in Osaka University Hospital 2. Patients who may receive anticoagulantion and cannot receive epidural anesthesia 3. Patients who can give written informed consent

Exclusion criteria

Exclusion criteria: 1. Patinets who are allergic to any medication used in the study 2. Pantients who have abdominal pain before surgery or use analgetic drugs for chronic pain 3. Patients who have severe paralysis or severe neurologic disease 4. Patients who are regarded ineligible by doctors with any other reasons

Design outcomes

Primary

Measure	Time frame
Cumulative fentanyl consumption in 48hours postoperation	—

Secondary

Measure	Time frame
1. Visual Analogue Scale (VAS) pain scores at rest and at mobilization after 4, 16, 24, 40 and 48hours postoperation. 2. Incidence of nausea and vomitting	—

Countries

Japan

Contacts

Public ContactAkihiko Maeda

Graduate School of Medicine, Osaka University Department of Anesthesiology and Intensive Care Medicine

amaeda@anes.med.osaka-u.ac.jp06-6879-3133

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026